Telix Pharmaceuticals (TLX AU): Stellar H1 Financial Performance; Eye on Upcoming Approval
Telix wins FDA approval for Pixclara, a radioactive diagnostic drug indicated for use with positron emission tomography for imaging gliomas (brain...
93 Views
Primer: Telix Pharmaceuticals (TLX AU) - Aug 2026
Telix is rapidly transitioning into a commercial-stage radiopharmaceutical leader, driven by the strong sales of its prostate cancer imaging...
102 Views
Strong Result, Can Telix Continue To Deliver?
Telix has continued to outperform operationally in 2026, but future upside is increasingly dependent on pipeline execution, regulatory approvals...
106 Views
APAC Healthcare Weekly (Sept 27) – Hansoh Pharma, Innocare, Astellas, Otsuka, Telix Pharmaceuticals
Hansoh’s risvutatug rezetecan has been included in NMPA’s Priority Review list. Elevar Therapeutics won FDA approval for Lyrfigtu for bile duct...
90 Views
APAC Healthcare Weekly (Sept 20) –Sino Bio, Impact Therapeutics, Takeda, Daiichi Sankyo, SK Biopharm
NMPA accepted Sino Bio’s NDA for bispecific ADC drug candidate. FDA granted priority review to Takeda’s zasocitinib for moderate-to-severe plaque...
92 Views